Pliant Therapeutics
Gregory Cosgrove MD is an accomplished medical professional with extensive experience in clinical development and leadership roles. Currently serving as Vice President of Clinical Development at Pliant Therapeutics since January 2021, Gregory previously held the position of Chief Medical Officer at the Pulmonary Fibrosis Foundation from 2014 to January 2021. Additionally, Gregory served as an Associate Professor at National Jewish Health from July 2002 until January 2021, contributing to the academic and clinical advancement in the field of pulmonary medicine.
Pliant Therapeutics
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.